chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Dizziness, Myalgia, NauseaVomiting, weakness, lethargy Dizzy, nausea, vomiting, myalgia, weak, lethargic; resolving.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19 with no symptoms Narrative:  Other Relevant History:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lethargy, Myalgia
Clinical narrative: Myalgia lethargic, chills
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Injection site pain, Myalgia
Clinical narrative: Myalgia pain at sige, redness, fever, chills and fatigue Narrative:  Other Relevant History:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Myalgia pain at sige, redness, fever, chills and fatigue Narrative:  Other Relevant History:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Impaired work ability
Clinical narrative: generalized weakness Narrative:  Per supervisor report, employee called off work today c/o generalized weakness  Other Relevant History:
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Myalgia, Pyrexia, Respiratory tract congestion
Clinical narrative: Headache, Myalgia, Fever, congestion, lymph node in left armpit Narrative:  Other Relevant History:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Impaired work ability, Myalgia, Pain
Clinical narrative: Myalgia, Arthralgia & Fever Narrative:  Employee got the second covid vaccine 02/04/2021 at  3pm Employee related to worsening body ache, fever, chills missed work 2/5/2021  Other Relevant History:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Myalgia, Arthralgia & Fever Narrative:  Employee got the second covid vaccine 02/04/2021 at  3pm Employee related to worsening body ache, fever, chills missed work 2/5/2021  Other Relevant History:
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Headache, Myalgia, Arthralgia, NauseaVomiting, Localized pain; fatigue Narrative:  Other Relevant History:
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vomiting
Clinical narrative: Headache, Myalgia, Arthralgia, NauseaVomiting, Localized pain; fatigue Narrative:  Other Relevant History:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hypoaesthesia, Impaired work ability, Myalgia
Clinical narrative: Headache, Myalgia, FACIAL NUMBNESS, TINGLING SENSATION AT THE EXTREMITIES Narrative:  Employee got the covid vaccine second dose , 02/04/21, 230pm Employee relates to facial numbness, tingling sensation at the extremities, body ache, chills This continues till the following day 2/5/2021 Employee missed work 2/5/2021, 02/08/2021  Other Relevant History:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paraesthesia
Clinical narrative: Headache, Myalgia, FACIAL NUMBNESS, TINGLING SENSATION AT THE EXTREMITIES Narrative:  Employee got the covid vaccine second dose , 02/04/21, 230pm Employee relates to facial numbness, tingling sensation at the extremities, body ache, chills This continues till the following day 2/5/2021 Employee missed work 2/5/2021, 02/08/2021  Other Relevant History:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache Narrative:  Other Relevant History:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever, chills, fatigue Narrative:  Other Relevant History:
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Fatigue, Pain
Clinical narrative: Dizziness CHEST PAIN; BODY PAIN; FATIGUE Narrative: STATES NEEDED TO TAKE NITROGLYCERINE FOR RELIEF  Other Relevant History:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Myalgia, Nausea, Pyrexia
Clinical narrative: Myalgia, Fever, NauseaVomiting, HIVES; SWELLING/REDNESS AT INJECTION SITE Narrative:  Other Relevant History:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vomiting
Clinical narrative: Myalgia, Fever, NauseaVomiting, HIVES; SWELLING/REDNESS AT INJECTION SITE Narrative:  Other Relevant History:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Malaise
Clinical narrative: Malaise Per supervisor report, employee called off work today c/o malaise.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Headache, Fever, FATIGUE; BODY ACHES; CHILLS Narrative:  Other Relevant History:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: Fever FLU-LIKE SYMPTOMS
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia, Sedation
Clinical narrative: Sedation, Myalgia, Fever, chills, shakes and fatigue. Narrative:  Other Relevant History:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Sedation, Myalgia, Fever, chills, shakes and fatigue. Narrative:  Other Relevant History:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Pain
Clinical narrative: Headache, Arthralgia, Fever, Localized pain; chills, fatigue Narrative:  Other Relevant History:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache, Arthralgia, Fever, Localized pain; chills, fatigue Narrative:  Other Relevant History:
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Insomnia, Myalgia
Clinical narrative: Headache, Myalgia, Fever, RIGORS/CHILLS; FATIGUE; INSOMNIA; NAUSEA Narrative:  SX WOULD COME AND GO OVER 24 HOURS  Other Relevant History:
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, RIGORS/CHILLS; FATIGUE; INSOMNIA; NAUSEA Narrative:  SX WOULD COME AND GO OVER 24 HOURS  Other Relevant History:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Hypertension, Injection site pain, Pain
Clinical narrative: Dizziness, HYPERtension, CHILLS; BODY ACHES; FATIGUE; SORENESS AT INJECTION SITE; VERTIGO Narrative:  Other Relevant History:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Dizziness, HYPERtension, CHILLS; BODY ACHES; FATIGUE; SORENESS AT INJECTION SITE; VERTIGO Narrative:  Other Relevant History:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Sedation, Myalgia, Fever, UrticariaPruritus, Diarrhea, NauseaVomiting, fatigue. pain, redness and swelling at the injection  site. Narrative:  Other Relevant History:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pruritus, Pyrexia, Sedation
Clinical narrative: Sedation, Myalgia, Fever, UrticariaPruritus, Diarrhea, NauseaVomiting, fatigue. pain, redness and swelling at the injection  site. Narrative:  Other Relevant History:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria, Vomiting
Clinical narrative: Sedation, Myalgia, Fever, UrticariaPruritus, Diarrhea, NauseaVomiting, fatigue. pain, redness and swelling at the injection  site. Narrative:  Other Relevant History:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pain
Clinical narrative: Headache, Myalgia, Fever, Localized pain; chills, fatigue Narrative:  Other Relevant History:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache, Myalgia, Fever, Localized pain; chills, fatigue Narrative:  Other Relevant History:
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Injection site erythema, Injection site pain
Clinical narrative: Headache, Arthralgia, chills, pain and redness at the injection site. Narrative:   Other Relevant History:
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Fever, Fever, Chills, Body aches, Dizzy, Fatigue, HA, Sore arm Narrative:  Other Relevant History:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, Fever, Chills, Body aches, Dizzy, Fatigue, HA, Sore arm Narrative:  Other Relevant History:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Impaired work ability, Myalgia, Pyrexia, Tremor
Clinical narrative: Headache, Myalgia, Fever, Shakiness Narrative:  On 1/21/21, day after 2nd vaccine, patiet awoke with headache, shakiness, low grade fever and increased myalgias. Missed work x 1 day. Symptoms lasted x 48 hours. No known prior COVID infection.  Other Relevant History:
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness bilateral
Clinical narrative: hearing loss Narrative:  Pt reported temporary hearing loss in both ears starting 2/6/2021 lasting approximately 4 days. Both ears have improved in hearing since then.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Diarrhoea, Eye pain, Headache
Clinical narrative: I experienced a hyper-reactive immune response after receving the first dose of COVID-19 vaccine on Friday 12/18/20. On Saturday, 12/19/20, I developed severe pharyngitis, swollen glands in my neck and jaw, blisters and ulcerations on my lips and area surrounding my mouth, intra-oral and buccal lesions, severe headache, photophobia and eye pain, myalgia, skin sensitivity, GI upset consisting of nausea and diarrhea, and lost my sense of taste and smell for 48 hours. I was not febrile. The symptoms were severe on 12/19 and 12/20, with improvement on Monday 12/21. I completed an event form with Pfizer documenting the hyper-reactivity.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperaesthesia, Laboratory test, Lip blister, Lymphadenopathy, Mouth ulceration
Clinical narrative: I experienced a hyper-reactive immune response after receving the first dose of COVID-19 vaccine on Friday 12/18/20. On Saturday, 12/19/20, I developed severe pharyngitis, swollen glands in my neck and jaw, blisters and ulcerations on my lips and area surrounding my mouth, intra-oral and buccal lesions, severe headache, photophobia and eye pain, myalgia, skin sensitivity, GI upset consisting of nausea and diarrhea, and lost my sense of taste and smell for 48 hours. I was not febrile. The symptoms were severe on 12/19 and 12/20, with improvement on Monday 12/21. I completed an event form with Pfizer documenting the hyper-reactivity.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Oral disorder, Pharyngitis, Pharyngitis streptococcal
Clinical narrative: I experienced a hyper-reactive immune response after receving the first dose of COVID-19 vaccine on Friday 12/18/20. On Saturday, 12/19/20, I developed severe pharyngitis, swollen glands in my neck and jaw, blisters and ulcerations on my lips and area surrounding my mouth, intra-oral and buccal lesions, severe headache, photophobia and eye pain, myalgia, skin sensitivity, GI upset consisting of nausea and diarrhea, and lost my sense of taste and smell for 48 hours. I was not febrile. The symptoms were severe on 12/19 and 12/20, with improvement on Monday 12/21. I completed an event form with Pfizer documenting the hyper-reactivity.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Photophobia, Swelling face
Clinical narrative: I experienced a hyper-reactive immune response after receving the first dose of COVID-19 vaccine on Friday 12/18/20. On Saturday, 12/19/20, I developed severe pharyngitis, swollen glands in my neck and jaw, blisters and ulcerations on my lips and area surrounding my mouth, intra-oral and buccal lesions, severe headache, photophobia and eye pain, myalgia, skin sensitivity, GI upset consisting of nausea and diarrhea, and lost my sense of taste and smell for 48 hours. I was not febrile. The symptoms were severe on 12/19 and 12/20, with improvement on Monday 12/21. I completed an event form with Pfizer documenting the hyper-reactivity.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling cold, Oxygen saturation decreased, Pallor, Pneumonia
Clinical narrative: 9 days post vaccination date, developed hives, pale, cold, Pulse Ox low, brain fog. Was seen in the ED, then admitted for bilateral pneumonia, Hospitalized x 5 days, 4 nights.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: 9 days post vaccination date, developed hives, pale, cold, Pulse Ox low, brain fog. Was seen in the ED, then admitted for bilateral pneumonia, Hospitalized x 5 days, 4 nights.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: Anaphylaxis; myocardial infarction; This is a spontaneous report from a contactable healthcare professional.  A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in the left arm on 04Jan2021, at 15:45 as first single dose for COVID-19 immunization.  Medical history included hypothyroidism, depression, anxiety and known allergy  to nickel from unknown dates.  Concomitant medication included thyroid (ARMOUR THYROID), liothyronine sodium (CYTOMEL), bupropion (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO).  On 04Jan2021, at  15:45, the patient experienced anaphylaxis and myocardial infarction, which were serious as they caused  hospitalization, disability, and were life threatening.  The patient was hospitalized for three days.  Therapeutic measures were taken as a result of anaphylaxis and myocardial infarction, noted as lots of medications,  intensive care unit (ICU) stay, continued unspecified medications. No covid was noted  prior to vaccination and no covid test post vaccination was reported. The outcome of anaphylaxis and myocardial infarction was not recovered.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events anaphylaxis and myocardial infarction cannot be excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute myocardial infarction, Anaphylactic reaction, Blood test, Computerised tomogram, Echocardiogram
Clinical narrative: Anaphylaxis; myocardial infarction; This is a spontaneous report from a contactable healthcare professional.  A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in the left arm on 04Jan2021, at 15:45 as first single dose for COVID-19 immunization.  Medical history included hypothyroidism, depression, anxiety and known allergy  to nickel from unknown dates.  Concomitant medication included thyroid (ARMOUR THYROID), liothyronine sodium (CYTOMEL), bupropion (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO).  On 04Jan2021, at  15:45, the patient experienced anaphylaxis and myocardial infarction, which were serious as they caused  hospitalization, disability, and were life threatening.  The patient was hospitalized for three days.  Therapeutic measures were taken as a result of anaphylaxis and myocardial infarction, noted as lots of medications,  intensive care unit (ICU) stay, continued unspecified medications. No covid was noted  prior to vaccination and no covid test post vaccination was reported. The outcome of anaphylaxis and myocardial infarction was not recovered.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events anaphylaxis and myocardial infarction cannot be excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Troponin
Clinical narrative: Anaphylaxis; myocardial infarction; This is a spontaneous report from a contactable healthcare professional.  A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in the left arm on 04Jan2021, at 15:45 as first single dose for COVID-19 immunization.  Medical history included hypothyroidism, depression, anxiety and known allergy  to nickel from unknown dates.  Concomitant medication included thyroid (ARMOUR THYROID), liothyronine sodium (CYTOMEL), bupropion (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO).  On 04Jan2021, at  15:45, the patient experienced anaphylaxis and myocardial infarction, which were serious as they caused  hospitalization, disability, and were life threatening.  The patient was hospitalized for three days.  Therapeutic measures were taken as a result of anaphylaxis and myocardial infarction, noted as lots of medications,  intensive care unit (ICU) stay, continued unspecified medications. No covid was noted  prior to vaccination and no covid test post vaccination was reported. The outcome of anaphylaxis and myocardial infarction was not recovered.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events anaphylaxis and myocardial infarction cannot be excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Myocardial infarction
Clinical narrative: Anaphylaxis; myocardial infarction; This is a spontaneous report from a contactable healthcare professional.  A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in the left arm on 04Jan2021, at 15:45 as first single dose for COVID-19 immunization.  Medical history included hypothyroidism, depression, anxiety and known allergy  to nickel from unknown dates.  Concomitant medication included thyroid (ARMOUR THYROID), liothyronine sodium (CYTOMEL), bupropion (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO).  On 04Jan2021, at  15:45, the patient experienced anaphylaxis and myocardial infarction, which were serious as they caused  hospitalization, disability, and were life threatening.  The patient was hospitalized for three days.  Therapeutic measures were taken as a result of anaphylaxis and myocardial infarction, noted as lots of medications,  intensive care unit (ICU) stay, continued unspecified medications. No covid was noted  prior to vaccination and no covid test post vaccination was reported. The outcome of anaphylaxis and myocardial infarction was not recovered.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events anaphylaxis and myocardial infarction cannot be excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Acute large, softball sized allergic reaction over the injection site -  swollen, raised, red, itchy, hives. Took benadryl/claratin for approx 1 week until it completely resolved.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site induration, Injection site pruritus
Clinical narrative: Acute large, softball sized allergic reaction over the injection site -  swollen, raised, red, itchy, hives. Took benadryl/claratin for approx 1 week until it completely resolved.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site erythema, Injection site inflammation, Injection site pruritus, Injection site rash, Injection site reaction
Clinical narrative: Acute large, softball sized allergic reaction over the injection site -  swollen, raised, red, itchy, hives. Took benadryl/claratin for approx 1 week until it completely resolved.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site swelling, Injection site urticaria
Clinical narrative: Acute large, softball sized allergic reaction over the injection site -  swollen, raised, red, itchy, hives. Took benadryl/claratin for approx 1 week until it completely resolved.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Dysphagia, Eye swelling, Hypersensitivity, Impaired work ability
Clinical narrative: On the 3rd - I started noticing my left eye swollen; on the 5th day day it felt weird - and it's getting bigger. My voice changed like a horse - hoarse throat. And when I swallowed it was like a piece of food in my throat. At work, my left eye is swollen  and my lower lip was swollen too and they took me to patient room at work and examined me. Asked me to go home from work and my husband took me to ED  on January 5th- I had gotten hives - started feeling itchy all over my body. At Emergency room they gave me Prednisone to stop the swelling. My throat was swollen and they gave me blood tests, too. Prednisone helped some - took that for one week. (Still missed work on the sixth because my eyes were still swollen.) Had a previously scheduled doctor appt for something else and my doctor told me the hives will come back after Prednisone so he told me to take Claritin for two weeks. All my symptoms resolved after that.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Swelling of eyelid, Throat tightness, Urticaria
Clinical narrative: On the 3rd - I started noticing my left eye swollen; on the 5th day day it felt weird - and it's getting bigger. My voice changed like a horse - hoarse throat. And when I swallowed it was like a piece of food in my throat. At work, my left eye is swollen  and my lower lip was swollen too and they took me to patient room at work and examined me. Asked me to go home from work and my husband took me to ED  on January 5th- I had gotten hives - started feeling itchy all over my body. At Emergency room they gave me Prednisone to stop the swelling. My throat was swollen and they gave me blood tests, too. Prednisone helped some - took that for one week. (Still missed work on the sixth because my eyes were still swollen.) Had a previously scheduled doctor appt for something else and my doctor told me the hives will come back after Prednisone so he told me to take Claritin for two weeks. All my symptoms resolved after that.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Dysphonia, Eye swelling, Impaired work ability, Lip swelling
Clinical narrative: On the 3rd - I started noticing my left eye swollen; on the 5th day day it felt weird - and it's getting bigger. My voice changed like a horse - hoarse throat. And when I swallowed it was like a piece of food in my throat. At work, my left eye is swollen  and my lower lip was swollen too and they took me to patient room at work and examined me. Asked me to go home from work and my husband took me to ED  on January 5th- I had gotten hives - started feeling itchy all over my body. At Emergency room they gave me Prednisone to stop the swelling. My throat was swollen and they gave me blood tests, too. Prednisone helped some - took that for one week. (Still missed work on the sixth because my eyes were still swollen.) Had a previously scheduled doctor appt for something else and my doctor told me the hives will come back after Prednisone so he told me to take Claritin for two weeks. All my symptoms resolved after that.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Pruritus, Sensation of foreign body, Throat irritation, Urticaria
Clinical narrative: On the 3rd - I started noticing my left eye swollen; on the 5th day day it felt weird - and it's getting bigger. My voice changed like a horse - hoarse throat. And when I swallowed it was like a piece of food in my throat. At work, my left eye is swollen  and my lower lip was swollen too and they took me to patient room at work and examined me. Asked me to go home from work and my husband took me to ED  on January 5th- I had gotten hives - started feeling itchy all over my body. At Emergency room they gave me Prednisone to stop the swelling. My throat was swollen and they gave me blood tests, too. Prednisone helped some - took that for one week. (Still missed work on the sixth because my eyes were still swollen.) Had a previously scheduled doctor appt for something else and my doctor told me the hives will come back after Prednisone so he told me to take Claritin for two weeks. All my symptoms resolved after that.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Paraesthesia, Rash, Rash pruritic
Clinical narrative: About 10 min post vaccination start feeling tingling in your hands and fingers. Consulted with MD on site that had stated others had complained about same reaction and was told to just observe. At night, I started itching really bad around 10:30PM and then I noticed a rash all over my body, both legs, specifically the right was worse. I also had patches on my arms and shoulders, also my chest and abdominal area.  The rash was really read and bumpy. (I took pictures of the progression of the rash if interested). I took Benadryl and  it barely helped me. Consulted with Employee Health who told me to consult with her PCP for advice.  He prescribed Prednisone for a week and did some labs. And to do a FU in a week.  The itching was unbearable. I even have like an electrical shock feeling in my skin since I started with this rash. I still feel it from time to time.  On my FU with Dr.  he noticed the rash was worse so he made me stop the Prednisone and wanted to do a biopsy from the tissue in my legs. Since I had the Prednisone in my system, I couldn't do it immediately, but was able to do it on 01/22/2021. Got my results the day before yesterday. It showed that I have what is called a Spongiopic dermatitis.  Dr called me and prescribed me bleach baths 3 times a week and another antibiotic. I am scheduled for my second dose on 02/16/2021.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Allergy test, Biopsy soft tissue, Eczema, Electric shock sensation, Paraesthesia
Clinical narrative: About 10 min post vaccination start feeling tingling in your hands and fingers. Consulted with MD on site that had stated others had complained about same reaction and was told to just observe. At night, I started itching really bad around 10:30PM and then I noticed a rash all over my body, both legs, specifically the right was worse. I also had patches on my arms and shoulders, also my chest and abdominal area.  The rash was really read and bumpy. (I took pictures of the progression of the rash if interested). I took Benadryl and  it barely helped me. Consulted with Employee Health who told me to consult with her PCP for advice.  He prescribed Prednisone for a week and did some labs. And to do a FU in a week.  The itching was unbearable. I even have like an electrical shock feeling in my skin since I started with this rash. I still feel it from time to time.  On my FU with Dr.  he noticed the rash was worse so he made me stop the Prednisone and wanted to do a biopsy from the tissue in my legs. Since I had the Prednisone in my system, I couldn't do it immediately, but was able to do it on 01/22/2021. Got my results the day before yesterday. It showed that I have what is called a Spongiopic dermatitis.  Dr called me and prescribed me bleach baths 3 times a week and another antibiotic. I am scheduled for my second dose on 02/16/2021.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Rash erythematous
Clinical narrative: About 10 min post vaccination start feeling tingling in your hands and fingers. Consulted with MD on site that had stated others had complained about same reaction and was told to just observe. At night, I started itching really bad around 10:30PM and then I noticed a rash all over my body, both legs, specifically the right was worse. I also had patches on my arms and shoulders, also my chest and abdominal area.  The rash was really read and bumpy. (I took pictures of the progression of the rash if interested). I took Benadryl and  it barely helped me. Consulted with Employee Health who told me to consult with her PCP for advice.  He prescribed Prednisone for a week and did some labs. And to do a FU in a week.  The itching was unbearable. I even have like an electrical shock feeling in my skin since I started with this rash. I still feel it from time to time.  On my FU with Dr.  he noticed the rash was worse so he made me stop the Prednisone and wanted to do a biopsy from the tissue in my legs. Since I had the Prednisone in my system, I couldn't do it immediately, but was able to do it on 01/22/2021. Got my results the day before yesterday. It showed that I have what is called a Spongiopic dermatitis.  Dr called me and prescribed me bleach baths 3 times a week and another antibiotic. I am scheduled for my second dose on 02/16/2021.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Dysarthria, Dyspnoea, Heart rate increased
Clinical narrative: Describe adverse reaction: vasovagal syncope several hours after vaccine. Sent to ED via ambulance. Vasovagal symptoms: dizziness; vertigo; lightheadedness; near syncope and weakness. Sent to ED via ambulance from work. ED gave IV fluids and mescaline.  Studies performed: EKG; CBC; and BMP. From ED MD note DC instructions: You came to our ER with concerns of dizziness after getting your covid vaccine. We evaluated you with labs, and provided you with meclizine and fluis. The results of our evaluation were reassuring, and we believe that the causes of your symptoms are not immediately life threatening and safe to follow up with your clinic doctors. We've prescribed you meclizine, take it as needed for dizziness. Administration error: no Clinic called No; Transferred to Emergency Department from workplace several hours after vaccine was administered.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Paraesthesia, Trismus, Vertigo, Vision blurred
Clinical narrative: Describe adverse reaction: vasovagal syncope several hours after vaccine. Sent to ED via ambulance. Vasovagal symptoms: dizziness; vertigo; lightheadedness; near syncope and weakness. Sent to ED via ambulance from work. ED gave IV fluids and mescaline.  Studies performed: EKG; CBC; and BMP. From ED MD note DC instructions: You came to our ER with concerns of dizziness after getting your covid vaccine. We evaluated you with labs, and provided you with meclizine and fluis. The results of our evaluation were reassuring, and we believe that the causes of your symptoms are not immediately life threatening and safe to follow up with your clinic doctors. We've prescribed you meclizine, take it as needed for dizziness. Administration error: no Clinic called No; Transferred to Emergency Department from workplace several hours after vaccine was administered.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness, Electrocardiogram, Full blood count, Metabolic function test
Clinical narrative: Describe adverse reaction: vasovagal syncope several hours after vaccine. Sent to ED via ambulance. Vasovagal symptoms: dizziness; vertigo; lightheadedness; near syncope and weakness. Sent to ED via ambulance from work. ED gave IV fluids and mescaline.  Studies performed: EKG; CBC; and BMP. From ED MD note DC instructions: You came to our ER with concerns of dizziness after getting your covid vaccine. We evaluated you with labs, and provided you with meclizine and fluis. The results of our evaluation were reassuring, and we believe that the causes of your symptoms are not immediately life threatening and safe to follow up with your clinic doctors. We've prescribed you meclizine, take it as needed for dizziness. Administration error: no Clinic called No; Transferred to Emergency Department from workplace several hours after vaccine was administered.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Presyncope, Syncope, Vertigo
Clinical narrative: Describe adverse reaction: vasovagal syncope several hours after vaccine. Sent to ED via ambulance. Vasovagal symptoms: dizziness; vertigo; lightheadedness; near syncope and weakness. Sent to ED via ambulance from work. ED gave IV fluids and mescaline.  Studies performed: EKG; CBC; and BMP. From ED MD note DC instructions: You came to our ER with concerns of dizziness after getting your covid vaccine. We evaluated you with labs, and provided you with meclizine and fluis. The results of our evaluation were reassuring, and we believe that the causes of your symptoms are not immediately life threatening and safe to follow up with your clinic doctors. We've prescribed you meclizine, take it as needed for dizziness. Administration error: no Clinic called No; Transferred to Emergency Department from workplace several hours after vaccine was administered.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Headache, Hypoaesthesia, Swelling face
Clinical narrative: Since my VAERS report # 228036  on January 8, 2021- I am still getting headaches - they come and go. Usually it's in the morning when I wake up. I take Tylenol and an hour or two they will be gone.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: Since my VAERS report # 228036  on January 8, 2021- I am still getting headaches - they come and go. Usually it's in the morning when I wake up. I take Tylenol and an hour or two they will be gone.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dry mouth, Dyspnoea, Full blood count, Paraesthesia oral
Clinical narrative: Tightness in chest, throat swelling, tongue tingling. Lasted about 45 minutes. Did NOT use epipen. Went to ER on site, received saline IV, was thoroughly checked and monitored, stayed 2 hours.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Electrocardiogram normal, Full blood count normal, Paraesthesia oral, Pharyngeal swelling
Clinical narrative: Tightness in chest, throat swelling, tongue tingling. Lasted about 45 minutes. Did NOT use epipen. Went to ER on site, received saline IV, was thoroughly checked and monitored, stayed 2 hours.
Age: 53.0
Sex: F
Vaccine: FLUR4, FLUR4
Symptoms: Electromyogram normal, Injection site discomfort, Injection site pain, Lack of vaccination site rotation, Loss of personal independence in daily activities
Clinical narrative: patient called approximately a month after the shot to report that her arm was still sore following the immunization. she stated that her arm was sore when she raised her arm. patient made and appointment with her pcp who sent her for an mri and referred her to a specialist. patient states she was told she will not be needing surgery but did receive a cortisone shot to try to help with the pain. the patient reported that the cortisone shot helped a little with the pain
Age: 53.0
Sex: F
Vaccine: FLUR4, FLUR4
Symptoms: Magnetic resonance imaging, Pain, Pain in extremity, Sleep disorder, Vaccination site movement impairment
Clinical narrative: patient called approximately a month after the shot to report that her arm was still sore following the immunization. she stated that her arm was sore when she raised her arm. patient made and appointment with her pcp who sent her for an mri and referred her to a specialist. patient states she was told she will not be needing surgery but did receive a cortisone shot to try to help with the pain. the patient reported that the cortisone shot helped a little with the pain
Age: 53.0
Sex: F
Vaccine: FLUR4, FLUR4
Symptoms: X-ray normal
Clinical narrative: patient called approximately a month after the shot to report that her arm was still sore following the immunization. she stated that her arm was sore when she raised her arm. patient made and appointment with her pcp who sent her for an mri and referred her to a specialist. patient states she was told she will not be needing surgery but did receive a cortisone shot to try to help with the pain. the patient reported that the cortisone shot helped a little with the pain
Age: 53.0
Sex: F
Vaccine: FLUR4, FLUR4
Symptoms: Limb discomfort
Clinical narrative: patient called approximately a month after the shot to report that her arm was still sore following the immunization. she stated that her arm was sore when she raised her arm. patient made and appointment with her pcp who sent her for an mri and referred her to a specialist. patient states she was told she will not be needing surgery but did receive a cortisone shot to try to help with the pain. the patient reported that the cortisone shot helped a little with the pain
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Paraesthesia oral, Pruritus, Swollen tongue, Wheezing
Clinical narrative: Patient sitting on exam table, speaking in full sentences and breathing comfortably but having diffuse itching.  Stated feels like internal itching.  Within 3 to 5 minutes lower lip felt numb " like when get dental procedure'. Tongue also a little numb. Given Benadryl 50 mg IM in the right deltoid. At 12:10 pm Itching persisted then given Prednisone 40 mg PO at 12:30pmUrticaria and angioedema starting within 3 minutes of the vaccine.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angioedema, Hypoaesthesia oral, Pruritus, Urticaria
Clinical narrative: Patient sitting on exam table, speaking in full sentences and breathing comfortably but having diffuse itching.  Stated feels like internal itching.  Within 3 to 5 minutes lower lip felt numb " like when get dental procedure'. Tongue also a little numb. Given Benadryl 50 mg IM in the right deltoid. At 12:10 pm Itching persisted then given Prednisone 40 mg PO at 12:30pmUrticaria and angioedema starting within 3 minutes of the vaccine.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Eyelid rash, Oropharyngeal pain, Pharyngeal swelling, Pulmonary oedema
Clinical narrative: infection; sore throat; pain in her lungs; pain in the left part of her back and the left axilla; pain in the left part of her back and the left axilla; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunisation. Patient age at vaccination was 40 years. The patient's medical history and concomitant medications were not reported. The patient reported she received the first vaccine on 28Dec2020 and on 04Jan2021 developed a sore throat, pain in her lungs and pain in the left part of her back and the left axilla. She went to the doctor and was told she had an infection and was given antibiotics but she still had symptoms. She went back and was given more antibiotics and the doctor ran some tests. The doctor said there looks like there is something going on with her blood and she has another appointment to discuss. She wanted to report this but also wanted to know what she could do for her symptoms. The final outcome of the events was unknown.  The information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary pain, Rash, Respiratory fatigue, Streptococcus test positive
Clinical narrative: infection; sore throat; pain in her lungs; pain in the left part of her back and the left axilla; pain in the left part of her back and the left axilla; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunisation. Patient age at vaccination was 40 years. The patient's medical history and concomitant medications were not reported. The patient reported she received the first vaccine on 28Dec2020 and on 04Jan2021 developed a sore throat, pain in her lungs and pain in the left part of her back and the left axilla. She went to the doctor and was told she had an infection and was given antibiotics but she still had symptoms. She went back and was given more antibiotics and the doctor ran some tests. The doctor said there looks like there is something going on with her blood and she has another appointment to discuss. She wanted to report this but also wanted to know what she could do for her symptoms. The final outcome of the events was unknown.  The information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Back pain, Infection, Oropharyngeal pain, Pulmonary pain
Clinical narrative: infection; sore throat; pain in her lungs; pain in the left part of her back and the left axilla; pain in the left part of her back and the left axilla; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunisation. Patient age at vaccination was 40 years. The patient's medical history and concomitant medications were not reported. The patient reported she received the first vaccine on 28Dec2020 and on 04Jan2021 developed a sore throat, pain in her lungs and pain in the left part of her back and the left axilla. She went to the doctor and was told she had an infection and was given antibiotics but she still had symptoms. She went back and was given more antibiotics and the doctor ran some tests. The doctor said there looks like there is something going on with her blood and she has another appointment to discuss. She wanted to report this but also wanted to know what she could do for her symptoms. The final outcome of the events was unknown.  The information on the lot/batch number has been requested.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pruritus, Rash maculo-papular
Clinical narrative: developing a diffuse rash on her body/it is a maculopapular rash mostly on her torso, chest, abdomen and it is now extending to her upper thighs; lesions on her chest; This is a spontaneous report from a contactable physician (patient). A 65-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EH9899, expiry date: unknown), intramuscular on 08Jan2021 09:00 at single dose (left upper arm) for COVID-19 immunization (prevent covid). Medical history included ongoing Hypertension (diagnosed a couple of years ago), ongoing Osteoporosis (diagnosed about 5 or 10 years ago, she does not take any medication for this), ongoing Grover's disease (diagnosed about 5 or 10 years ago). There were no concomitant medications. The patient received her first dose of bnt162b2 on 18Dec2020 around 13:30, in the upper left arm for COVID-19 immunization. She confirms she received the same lot number for both doses. Vaccination facility type was hospital. The patient received vaccine about 10 days ago. She is developing a diffuse rash on her body (Jan2021). She would like to know if there is any guidance on how to treat rash. She has a history of Grover's and she had lesions on her chest about a week ago (Jan2021), she put some cortisone cream on it.  She noticed that her whole abdomen had the rash, states it is not itchy. She really noticed the rash yesterday. She stated that it is a maculopapular rash mostly on her torso, chest, abdomen and it is now extending to her upper thighs. States the lesions occurred about one or two weeks ago and she is not sure if that was before or after the second dose of the vaccine. She clarified that she received the second dose of the vaccine twelve days ago, not ten days ago. When querying causality, states there is no other reason for the rash, so it is probably related to the vaccine. The outcome of the event developing a diffuse rash on her body/it is a maculopapular rash mostly on her torso, chest, abdomen and it is now extending to her upper thighs was not recovered, while for other event was unknown. Therapeutic measures were taken as a result of lesions on her chest.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rash maculo-papular, Skin lesion
Clinical narrative: developing a diffuse rash on her body/it is a maculopapular rash mostly on her torso, chest, abdomen and it is now extending to her upper thighs; lesions on her chest; This is a spontaneous report from a contactable physician (patient). A 65-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EH9899, expiry date: unknown), intramuscular on 08Jan2021 09:00 at single dose (left upper arm) for COVID-19 immunization (prevent covid). Medical history included ongoing Hypertension (diagnosed a couple of years ago), ongoing Osteoporosis (diagnosed about 5 or 10 years ago, she does not take any medication for this), ongoing Grover's disease (diagnosed about 5 or 10 years ago). There were no concomitant medications. The patient received her first dose of bnt162b2 on 18Dec2020 around 13:30, in the upper left arm for COVID-19 immunization. She confirms she received the same lot number for both doses. Vaccination facility type was hospital. The patient received vaccine about 10 days ago. She is developing a diffuse rash on her body (Jan2021). She would like to know if there is any guidance on how to treat rash. She has a history of Grover's and she had lesions on her chest about a week ago (Jan2021), she put some cortisone cream on it.  She noticed that her whole abdomen had the rash, states it is not itchy. She really noticed the rash yesterday. She stated that it is a maculopapular rash mostly on her torso, chest, abdomen and it is now extending to her upper thighs. States the lesions occurred about one or two weeks ago and she is not sure if that was before or after the second dose of the vaccine. She clarified that she received the second dose of the vaccine twelve days ago, not ten days ago. When querying causality, states there is no other reason for the rash, so it is probably related to the vaccine. The outcome of the event developing a diffuse rash on her body/it is a maculopapular rash mostly on her torso, chest, abdomen and it is now extending to her upper thighs was not recovered, while for other event was unknown. Therapeutic measures were taken as a result of lesions on her chest.